May 20, 2021
A June 28 deadline for creditors of bankrupt pharmaceutical company Mallinckrodt to file proofs of claim against the company overcame objections from a group of plaintiffs alleging price-fixing damages Thursday, with a Delaware judge saying opposition to the debtor's proposed noticing procedures was unfounded.
May 18, 2021
Drug buyers alleging bankrupt pharmaceutical company Mallinckrodt PLC overcharged for its Acthar Gel medication have again told a Delaware judge that a Chapter 11 trustee must take over the case, saying Mallinckrodt's leadership lacks the competence necessary to complete the reorganization.
April 13, 2021
Mallinckrodt PLC urged a Delaware bankruptcy judge Monday to reject a bid to disqualify Arnold & Porter from serving as special counsel in its Chapter 11, arguing certain litigants are attempting to have the firm booted based on "rank speculation and fanciful conspiracy theories."
April 05, 2021
A Delaware bankruptcy judge on Monday gave drugmaker Mallinckrodt PLC permission to give its top executives up to $35 million in performance-based bonuses, rejecting creditor arguments that the executives could be responsible for the company's legal troubles.
March 31, 2021
Drugmaker Mallinckrodt PLC Wednesday asked a Delaware bankruptcy judge to allow it to pay more than $35 million in bonuses to its top executives, while creditors argued the bonuses could reward the executives who sent the company into Chapter 11.